These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30455201)

  • 1. PPE37 Is Essential for
    Tullius MV; Nava S; Horwitz MA
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30455201
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting Function of Structured N-Terminal and Unstructured C-Terminal Segments of
    Ahmad J; Farhana A; Pancsa R; Arora SK; Srinivasan A; Tyagi AK; Babu MM; Ehtesham NZ; Hasnain SE
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Mycobacterium tuberculosis PPE37 protein in Mycobacterium smegmatis induces low tumour necrosis factor alpha and interleukin 6 production in murine macrophages.
    Daim S; Kawamura I; Tsuchiya K; Hara H; Kurenuma T; Shen Y; Dewamitta SR; Sakai S; Nomura T; Qu H; Mitsuyama M
    J Med Microbiol; 2011 May; 60(Pt 5):582-591. PubMed ID: 21233299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
    Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
    J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPE Surface Proteins Are Required for Heme Utilization by Mycobacterium tuberculosis.
    Mitra A; Speer A; Lin K; Ehrt S; Niederweis M
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
    Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
    Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 25-kilodalton protein of Mycobacterium bovis BCG to distinguish BCG strains from Mycobacterium tuberculosis.
    Kumar D; Srivastava BS; Singh NB; Srivastava R
    J Clin Microbiol; 1996 Jan; 34(1):224-6. PubMed ID: 8748313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel polymorphic genetic locus in members of the Mycobacterium tuberculosis complex.
    Rauzier J; Gormley E; Gutierrez MC; Kassa-Kelembho E; Sandall LJ; Dupont C; Gicquel B; Murray A
    Microbiology (Reading); 1999 Jul; 145 ( Pt 7)():1695-1701. PubMed ID: 10439408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
    Prygiel M; Janaszek-Seydlitz W; Bucholc B
    Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCG.
    Lu MC; Lien MH; Becker RE; Heine HC; Buggs AM; Lipovsek D; Gupta R; Robbins PW; Grosskinsky CM; Hubbard SC
    Infect Immun; 1987 Oct; 55(10):2378-82. PubMed ID: 2820881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphisms that cause structural changes in the cyclic AMP receptor protein transcriptional regulator of the tuberculosis vaccine strain Mycobacterium bovis BCG alter global gene expression without attenuating growth.
    Hunt DM; Saldanha JW; Brennan JF; Benjamin P; Strom M; Cole JA; Spreadbury CL; Buxton RS
    Infect Immun; 2008 May; 76(5):2227-34. PubMed ID: 18332206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.
    Berthet FX; Lagranderie M; Gounon P; Laurent-Winter C; Ensergueix D; Chavarot P; Thouron F; Maranghi E; Pelicic V; Portnoï D; Marchal G; Gicquel B
    Science; 1998 Oct; 282(5389):759-62. PubMed ID: 9784137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.
    Festjens N; Bogaert P; Batni A; Houthuys E; Plets E; Vanderschaeghe D; Laukens B; Asselbergh B; Parthoens E; De Rycke R; Willart MA; Jacques P; Elewaut D; Brouckaert P; Lambrecht BN; Huygen K; Callewaert N
    EMBO Mol Med; 2011 Apr; 3(4):222-34. PubMed ID: 21328541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG.
    Shinnick TM; Sweetser D; Thole J; van Embden J; Young RA
    Infect Immun; 1987 Aug; 55(8):1932-5. PubMed ID: 2440811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
    Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW
    PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient testing of large pools of Mycobacterium tuberculosis RD1 peptides and identification of major antigens and immunodominant peptides recognized by human Th1 cells.
    Mustafa AS; Al-Attiyah R; Hanif SN; Shaban FA
    Clin Vaccine Immunol; 2008 Jun; 15(6):916-24. PubMed ID: 18400977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.